Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Asarina Pharma AB (publ)

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 107 More Arrow 438 More Arrow 526
Earnings before taxes -14,578 Less Arrow -14,828 Less Arrow -38,297
EBITDA -14,217 Less Arrow -14,281 Less Arrow -37,896
Total assets 6,077 More Arrow 16,857 More Arrow 30,361
Current assets 5,297 More Arrow 15,675 More Arrow 28,883
Current liabilities 4,428 Less Arrow 2,255 More Arrow 9,217
Equity capital 1,649 More Arrow 14,602 More Arrow 21,144
- share capital 5,660 Equal arrow 5,660 Less Arrow 4,686
Employees (average) 5 Equal arrow 5 More Arrow 6

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 27.1% More Arrow 86.6% Less Arrow 69.6%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -238.1% More Arrow -85.4% Less Arrow -124.4%
Current ratio 119.6% More Arrow 695.1% Less Arrow 313.4%
Return on equity (ROE) -884.1% More Arrow -101.5% Less Arrow -181.1%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Less Arrow -1 Equal arrow -1
Chg. No. of employees % 0% Less Arrow -17% More Arrow -14%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.